Evoke Pharma Files Q1 2025 10-Q
| Field | Detail |
|---|---|
| Company | Evoke Pharma Inc |
| Form Type | 10-Q |
| Filed Date | May 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, pharmaceuticals, financial-reporting
TL;DR
Evoke Pharma's Q1 2025 10-Q is in. Details on warrants and agreements.
AI Summary
Evoke Pharma Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates. Key events mentioned include the Series C Warrants and the EVER SAN Agreement, indicating ongoing corporate activities and strategic partnerships.
Why It Matters
This filing provides investors with a quarterly update on Evoke Pharma's financial health and strategic initiatives, crucial for understanding the company's trajectory.
Risk Assessment
Risk Level: medium — The company's financial status and ongoing warrant activities suggest potential volatility and financial risk.
Key Numbers
- 20250331 — Reporting Period End Date (Indicates the end of the fiscal quarter covered by the report.)
- 20250513 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Evoke Pharma Inc (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 420 STEVENS AVENUE, SUITE 230, SOLANA BEACH, CA 92075 (address) — Company's business and mailing address
- EVERSANAAgreementMember (agreement) — A specific agreement mentioned in the filing
- SeriesCWarrantsMember (financial_instrument) — A type of warrant discussed
FAQ
What is the primary business of Evoke Pharma Inc.?
Evoke Pharma Inc. is in the business of Pharmaceutical Preparations, as indicated by its SIC code [2834].
What is the fiscal year end for Evoke Pharma Inc.?
Evoke Pharma Inc.'s fiscal year ends on December 31st.
When was the EVER SAN Agreement entered into?
The EVER SAN Agreement was entered into on February 1, 2022.
What period does this 10-Q filing cover?
This 10-Q filing covers the period ending March 31, 2025.
What is the company's incorporation state?
Evoke Pharma Inc. is incorporated in Delaware (DE).
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding Evoke Pharma Inc.